SR 11237,泛RXR激动剂
|
S287354-25mg
|
Moligand™, ≥98%(HPLC) |
146670-40-8 |
25mg
|
¥ 3706.9
|
现货 |
阿拉丁 |
SR 11237,泛RXR激动剂
|
S287354-100mg
|
Moligand™, ≥98%(HPLC) |
146670-40-8 |
100mg
|
¥ 10299.9
|
现货 |
阿拉丁 |
(±)-Α-甲基-(4-羧苯基)甘氨酸
|
M274690-25mg
|
≥95% |
146669-29-6 |
25mg
|
¥ 1502.9
|
现货 |
阿拉丁 |
(±)-Α-甲基-(4-羧苯基)甘氨酸
|
M274690-5mg
|
≥95% |
146669-29-6 |
5mg
|
¥ 619.9
|
现货 |
阿拉丁 |
(±)-Α-甲基-(4-羧苯基)甘氨酸
|
M274690-1mg
|
≥95% |
146669-29-6 |
1mg
|
¥ 272.9
|
现货 |
阿拉丁 |
(±)-Α-甲基-(4-羧苯基)甘氨酸
|
M274690-100mg
|
≥95% |
146669-29-6 |
100mg
|
¥ 6118.9
|
现货 |
阿拉丁 |
氟奋乃静d8二盐酸盐
|
F395691-5mg
|
≥98 atom% D,≥98% |
146-56-5 |
5mg
|
¥ 8239.9
|
现货 |
阿拉丁 |
(S)-(-)-α-甲基苄基异氰酸酯
|
I132137-100g
|
≥99% |
14649-03-7 |
100g
|
¥ 1805.9
|
期货,请咨询 |
阿拉丁 |
戊基 2-(乙酰氨基)-2-脱氧-β-D-吡喃葡萄糖苷 3,4,6-三乙酸酯
|
A354232-50mg
|
≥98% |
146288-30-4 |
50mg
|
¥ 274.9
|
现货 |
阿拉丁 |
戊基 2-(乙酰氨基)-2-脱氧-β-D-吡喃葡萄糖苷 3,4,6-三乙酸酯
|
A354232-250mg
|
≥98% |
146288-30-4 |
250mg
|
¥ 898.9
|
现货 |
阿拉丁 |
2-苄氧基溴乙烷
|
B107737-500g
|
≥97% |
1462-37-9 |
500g
|
¥ 2221.9
|
现货 |
阿拉丁 |
PFK158
|
P414193-50mg
|
≥95% |
1462249-75-7 |
50mg
|
¥ 3398.9
|
现货 |
阿拉丁 |
PFK158
|
P414193-25mg
|
≥95% |
1462249-75-7 |
25mg
|
¥ 1895.9
|
现货 |
阿拉丁 |
PFK158
|
P414193-10mg
|
≥95% |
1462249-75-7 |
10mg
|
¥ 925.9
|
现货 |
阿拉丁 |
GJ103
|
G412297-250mg
|
≥98% |
1459687-89-8 |
250mg
|
¥ 1537.9
|
现货 |
阿拉丁 |
GJ103
|
G412297-100mg
|
≥98% |
1459687-89-8 |
100mg
|
¥ 1005.9
|
现货 |
阿拉丁 |
N-辛酰基-D-赤型-神经鞘氨醇
|
N130688-1mg
|
≥98% |
145774-33-0 |
1mg
|
¥ 538.9
|
现货 |
阿拉丁 |
HG-9-91-01
|
H413999-25mg
|
Moligand™, ≥99% |
1456858-58-4 |
25mg
|
¥ 2965.9
|
现货 |
阿拉丁 |
HG-9-91-01
|
H413999-100mg
|
Moligand™, ≥99% |
1456858-58-4 |
100mg
|
¥ 10299.9
|
现货 |
阿拉丁 |
SH-4-54
|
S413742-50mg
|
≥97% |
1456632-40-8 |
50mg
|
¥ 2678.9
|
现货 |
阿拉丁 |
SH-4-54
|
S413742-25mg
|
≥97% |
1456632-40-8 |
25mg
|
¥ 1760.9
|
现货 |
阿拉丁 |
SH-4-54
|
S413742-100mg
|
≥97% |
1456632-40-8 |
100mg
|
¥ 4170.9
|
现货 |
阿拉丁 |
JG98
|
J413598-50mg
|
≥99% |
1456551-16-8 |
50mg
|
¥ 8898.9
|
现货 |
阿拉丁 |
JG98
|
J413598-25mg
|
≥99% |
1456551-16-8 |
25mg
|
¥ 6117.9
|
现货 |
阿拉丁 |